Search for: "Bristol Associates, Inc., in the Matter of" Results 41 - 55 of 55
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Apr 2010, 5:01 am by Broc Romanek
" The Australian Shareholders Association (ASA) said that the response was "much stronger than they had anticipated. [read post]
23 Jun 2019, 4:25 pm by INFORRM
Mr Johnson has repeatedly refused to answer questions about the incident and his supporters have suggested that this was a private matter. [read post]
27 Apr 2007, 12:04 pm
Issa suggested that perhaps "one window" might be provided for a post-grant proceeding, one shot at a patent, no matter when that window would be. [read post]
10 Oct 2016, 2:59 pm by Michael Grossman
Made by Bristol-Myers Squibb, Taxol is also used as a component of intravenous chemotherapy. [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva… [read post]
19 Sep 2008, 6:00 pm
: (IPRoo), Giving Goliath the slingshot: Review of the National Innovation System on 'the costs of enforcing IP rights': (Australia & New Zealand Intellectual Property Law), Take patent policy away from lawyers, says Australian government report: (IAM), Advisory Council announces review of scope of patentable subject matter: (International Law Office), Federal Court's flu shot for patent law: Notice to Practitioners - Proceedings under the Patents Act 1990 (Cth):… [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
12 Feb 2014, 9:25 am
Against Christ Church in Savannah, Georgia, GA; Bishop of the Episcopal Diocese of Georgia, Inc., The Episcopal Church, et al. v. [read post]
7 Jun 2010, 9:54 am by smtaber
In a recent enforcement action, EPA alleged that Michael Perugini violated the federal Lead Disclosure Rule when he failed to disclose information about lead paint to seven tenants when leasing units at his Bristol apartment buildings. [read post]
7 Jun 2010, 10:04 am by Steven M. Taber
In a recent enforcement action, EPA alleged that Michael Perugini violated the federal Lead Disclosure Rule when he failed to disclose information about lead paint to seven tenants when leasing units at his Bristol apartment buildings. [read post]
18 Apr 2012, 4:40 pm by Schachtman
Bristol-Meyers Squibb Co., 1998 WL 812318, at *23 (M.D. [read post]
22 Feb 2015, 1:44 pm
Against Trinity Anglican Church in Bristol, Connecticut (CT); plaintiff is the Diocese of Connecticut; case settled in 2008; congregation left property to the Diocese31. [read post]